Skip to main content
. 2024 Jun 4;14:1394070. doi: 10.3389/fcimb.2024.1394070

Figure 3.

Figure 3

PMN bactericidal activity. PMN bactericidal activity against Staphylococcus aureus at PT1 (1 month post- treatment initiation) in experimental groups (n = 3) non-challenged controls (NC), commercial vaccine (CV), commercial vaccine and probiotic (CV-PR), and probiotic (PR). ANOVA with Tukey’s post-hoc test was applied, and the significant levels were **p < 0.01 and *p < 0.05.